Scientific publications - March 18, 2024
Device and drug shortages in Europe persist, new survey shows
Countries across the globe face a wide range of challenges in accessing necessary health products, such as shortages and stockouts.1…
Device and drug shortages in Europe persist, new survey shows
Countries across the globe face a wide range of challenges in accessing necessary health products, such as shortages and stockouts.1…
Scientific evidence on VATs: Is there enough? Is it robust?
There is much scientific evidence available on the efficacy of vascular access teams (VATs) in managing costs, preventing intravenous (IV)…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
Long peripheral catheters: Tell us what you think
The use of ultrasound to guide peripheral intravenous catheter (PIVC) insertion can improve insertion success in patients with difficult venous…
How to turn a PICC team into a vascular access team
On the second day of BD MACOV@23, a virtual edition of the Multidisciplinary Advanced Course on Vascular Access (MACOVA) held…
Best practices for phase 1 investigational drugs trials
Before pharmaceutical products are released onto the market, they undergo extensive screening as an investigational drug (IND, or investigational new…
Key insights on recent amendments to EU-MDR
The European Medical Device Regulation (EU-MDR) 2017/745 has brought many changes to the medical device industry and product availability. Thanks…
Fast fact
“I think that the biggest issue in our service is choosing which [vascular access device (VAD)] for which patients,” Professor Caren Randon, MD, PhD